-transparent.png){kind=logo}
A double blind study has been lead on 75 patients affected by head and neck cancer treated with CDDP, to verify the alizapride's antiemetic efficacy versus placebo and metoclopramide. On 76 patients examined, 28 has been treated with CDDP 50 mg/mq + alizapride; 28 with CDDP 50 mg/mq + metoclopramide and finally 19 with CDDP 50 mg/mq + placebo. Both alizapride and metoclopramide administered have resulted effective on the control of the emesis induced with CDDP without side effects.
Related Publications
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
January 1987,
Giornale italiano di oncologia,
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
January 1991,
Acta oncologica (Stockholm, Sweden),
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
March 1984,
Annals of internal medicine,
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
January 1987,
Cancer chemotherapy and pharmacology,
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
March 1989,
Japanese journal of clinical oncology,
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
November 1985,
Cancer treatment reports,
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
January 1984,
Cancer chemotherapy and pharmacology,
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
February 1989,
Cancer,
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
November 1988,
Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
A Denaro, and
M Rossi, and
A Garozzo, and
M Matera, and
V Neri
February 1991,
Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
